Elekta (OTCMKTS:EKTAY) Sees Strong Trading Volume – Here’s What Happened

Elekta AB (OTCMKTS:EKTAY) shares saw unusually-high trading volume on Monday . Approximately 3,119 shares were traded during trading, an increase of 14% from the previous session’s volume of 2,725 shares.The stock last traded at $4.94 and had previously closed at $4.7704.

Analyst Ratings Changes

Separately, Zacks Research cut shares of Elekta from a “hold” rating to a “strong sell” rating in a report on Tuesday, June 2nd. Two equities research analysts have rated the stock with a Sell rating, Based on data from MarketBeat, the company has an average rating of “Sell”.

Elekta Price Performance

The firm has a market capitalization of $1.83 billion, a PE ratio of -31.00 and a beta of 1.01. The company has a current ratio of 0.87, a quick ratio of 0.68 and a debt-to-equity ratio of 0.47. The company has a fifty day moving average price of $5.35 and a two-hundred day moving average price of $5.87.

Elekta (OTCMKTS:EKTAY) last released its quarterly earnings results on Thursday, May 28th. The company reported $0.06 EPS for the quarter. Elekta had a positive return on equity of 11.11% and a negative net margin of 3.32%.The company had revenue of $521.00 million for the quarter. Sell-side analysts forecast that Elekta AB will post 0.43 earnings per share for the current year.

About Elekta

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.